Rare Disease Spotlight: Transthyretin Amyloidosis Cardiomyopathy (ATTR‐CM) Disease Burden, Unmet Needs, and Treatment Advances

Pricing: Free for Members and Non-Members

Course Description

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) is a rare and progressive disease characterized by the misfolding of amyloid fibrils that aggregate and deposit locally in one specific area of the body or deposit systemically which affects many tissues and organs. The disease burden of ATTR-CM is considerable, given its progressive nature and symptoms of chronic heart failure and significant impact on patients' quality of life and survival. In the US, significant diagnostic gaps are evident among Black and Hispanic/Latinx communities with ATTR-CM. The estimated healthcare cost to treat all eligible ATTR-CM patients is $32.3 billion annually.

The faculty for this session will provide an in-depth knowledge of ATTR-CM disease burden, unmet care needs, patient value, timely clinical data on new and emerging therapies, and, more broadly, managed care approaches to optimize health outcomes.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Define transthyretin amyloidosis cardiomyopathy, including clinical manifestation, screening diagnosis, and at‐risk populations.
  2. Explain the disease burden of ATTR‐CM from a patient perspective in relation to the quality of the lived experience and treatment value.
  3. Identify unmet needs in ATTR‐CM by evaluating new and emerging therapeutic options to distinguish clinical efficacy, safety, and dosing.
  4. Discuss managed care considerations to incorporate the patient value and access to innovative therapies into managed care decision‐making for improved health outcomes.

Commercial Support

This activity is supported by an independent medical education grant from BridgeBio Pharma, Inc.

Course summary
Available credit: 
  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion
Course opens: 
11/11/2024
Course expires: 
12/31/2025
Cost:
$0.00

Timothy O'Shea, MS, PharmD

Director, Specialty Pharmacy
Horizon Blue Cross Blue Shield of New Jersey
Newark, NJ

Erin Poyant

Senior Manager of Education and Awareness
Amyloidosis Research Consortium
Newton , MA

Sean M. Riley, MSOL

Patient Speaker/Educator
Amyloidosis Speakers Bureau
Merrimack, NH

Tyler Sandahl, PharmD, BCOP

Multiple Myeloma Clinical Pharmacy Specialist
Mayo Clinic
Rochester, MN

Disclosures

Faculty/Reviewer/Planner​

Reported Relevant Financial Relationships​

Timothy O’Shea, MS, PharmD​

Faculty​

Disclosed no relevant financial relationships.​

Erin Poyant​

Faculty​

Disclosed no relevant financial relationships.​

Sean M. Riley, MSOL​

Faculty​

Advisor, Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds): Alnylam​

Tyler Sandahl, BCOP​

Faculty​

Advisory Board: BioLineRx, Pfizer Inc.​

Consultant: Johnson & Johnson​

Curtis Wander​

Reviewer​

Disclosed no relevant financial relationships.​

​

Jennifer Evans​

Planner​

Disclosed no relevant financial relationships.​

​

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-24-048-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: November 11, 2024 •  Expiration Date: December 31, 2025
Activity Fee: Free for Members and Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion

Price

Cost:
$0.00
Please login or register to take this course.